DexCom DXCM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 239.4%+2.1pp | 237.3%-0.4pp | 237.7%-2.7pp | 240.3%-4.0pp | 244.3%-3.4pp | |
| Operating margin | 74.2%+6.2pp | 68%+4.7pp | 63.3%+1.3pp | 62%-1.3pp | 63.3%-1.9pp | |
| Net margin | 66.5%+6.4pp | 60.1%+3.7pp | 56.4%-1.3pp | 57.7%-3.7pp | 61.4%-3.9pp | |
| EBITDA margin | 95.9%+6.1pp | 89.7%+4.7pp | 85.1%+1.4pp | 83.7%-1.1pp | 84.7%-1.6pp | |
| Free cash flow margin | 89.6%+15.8pp | 73.8%+7.5pp | 66.3%+10.0pp | 56.3%-3.6pp | 59.9%-1.5pp | |
| Returns | ||||||
| Return on equity | 123.6%+11.9pp | 111.7%+6.9pp | 104.8%-1.4pp | 106.2%-6.6pp | 112.8%-4.8pp | |
| Return on assets | 45.4%+5.8pp | 39.6%+4.0pp | 35.6%-0.1pp | 35.7%-1.7pp | 37.4%-2.6pp | |
| Return on invested capital | 162.1%+15.5pp | 146.6%+9.2pp | 137.4%+11.9pp | 125.5%-9.4pp | 135%-1.3pp | |
| Efficiency | ||||||
| Asset turnover | 2.7×+0.1× | 2.6×+0.1× | 2.5×0.0× | 2.5×0.0× | 2.4×0.0× | |
| Inventory turnover | 12.4×0.0× | 12.4×+0.3× | 12.1×+0.3× | 11.8×+0.2× | 11.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.9×+0.4× | 6.5×+0.4× | 6.1×-0.9× | 6.9×-1.3× | 8.2×-1.4× | |
| Quick ratio | 6×+0.3× | 5.6×+0.3× | 5.3×-0.7× | 6.1×-1.1× | 7.2×-1.2× | |
| Cash ratio | 1.8×+0.2× | 1.6×+0.2× | 1.4×+0.2× | 1.2×-0.2× | 1.4×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -4.2×+0.1× | -4.3×-0.1× | -4.2×-1.1× | -3.1×-0.2× | -2.9×-0.1× | |
| Per Share | ||||||
| Book value per share | $27.28+7.7% | $25.33+7.1% | $23.65+8.6% | $21.78+2.2% | $21.32+0.8% | |
| Valuation | ||||||
| Market capitalization | $110.78B-2.3% | $113.39B-3.8% | $117.88B-0.4% | $118.36B-8.3% | $129.11B-17.1% | |
| Enterprise value | $106.31B-2.6% | $109.12B-4.2% | $113.92B-1.5% | $115.64B-8.7% | $126.63B-17.4% | |
| Price / earnings | 153.6×-24.1× | 177.7×-21.8× | 199.4×-2.8× | 202.3×-7.5× | 209.8×-33.6× | |
| Price / sales | 24.4×-1.4× | 25.8×-2.0× | 27.8×-1.0× | 28.8×-3.5× | 32.2×-7.6× | |
| Price / book | 40.6×-3.6× | 44.3×-5.0× | 49.3×-3.9× | 53.2×-5.2× | 58.4×-12.0× | |
| EV / EBITDA | 99.8×-12.4× | 112.1×-15.0× | 127.1×-7.3× | 134.4×-13.9× | 148.3×-31.9× | |
| EV / sales | 23.4×-1.5× | 24.9×-2.0× | 26.9×-1.2× | 28.1×-3.5× | 31.6×-7.6× | |
| Free cash flow yield | 15.8%+3.8pp | 12%+2.1pp | 9.9%+2.0pp | 7.9%+0.2pp | 7.7%+1.1pp | |
| Earnings yield | 11.5%+1.9pp | 9.6%+1.3pp | 8.3%+0.2pp | 8.1%+0.2pp | 7.9%+0.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are DexCom's profit margins?
- DexCom (DXCM) runs a 61.5% gross margin and a 21.4% operating margin, with a 19.3% net margin.
- Where do DexCom's ratios come from?
- Every ratio is computed from DexCom's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
